[4] Funck-Brentano C, Becquemont L, Leneveu A, et al.Inhibition by omeprazole ofproguanil metabolism: mechanism of the interaction in vitro and prediction of in-vivo results from the in-vitro experiments[J]. Pharmacol Exp
Ther,1997,280（2）：730-738.
[5] Tanigawara Y, Kita T,Hirono M, et al. Identification of N-Acetyltransferase 2 and CYP2C19 Genotypes for hair, buccal cell swabs, or fingernails compared with blood[J]. Ther Drug Monit,2001,23(4):341-346.
[6]何兴祥,赵英恒, 郝元涛,等.CYP2C19基因多态性对雷贝拉唑三联疗法根除幽门螺杆菌疗效的
影响[J]. 中华内科杂志, 2004,43(1):13-15.
[7] 姜英杰,李瑜元,聂玉强,等.雷贝拉唑根除幽门螺杆菌疗效及其与CYP2C19基因多态性的关系[J]. 广州医学院学报, 2004,32(3):22-25.
[8]Ando T,Kato H,Sugimoto N,et al.A comparative study on endoscopic ulcer healing of omeprazole versus rabeprazole with respect to CYP2C19 genotypic differences[J]. Dig Dis Sci, 2005,50(9):1625-1631.
[9]Takada K,Arefayene M,Desta Z, et al.Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis[J]. Arthritis Rheum,2004,50(7):2202-2210.
[10]齐晓涟，黄越，王育琴，等.苯妥英钠血药浓度与CYP2C19基因多态性关系的研究[J].中国新药杂志, 2004,13(10):922-925.
[11] 余帮宁，陈国林，何楠，等.CYP2C19基因多态性对西酞普兰药代动力学的影响[J]. 中国药理通讯, 2003,20(2):46-48.
[12] Selim K, Atila B, Lise B,et al. CYP2C19 genotype does not represent a genetic predisposition in idiopathic systemic lupus erythematosus[J]. Ann Rheum Dis,1999,5(8):182-185.
[13] 陈静，陆峥，江三多,等.细胞色素P450酶1A2和2C19基因多态性与难治性抑郁症的关联
分析[J]. 上海精神医学,2005,17(2):95-98.
[14] Wei-Xing Shi, Shu-Qing Chen. Frequencies of poor metabolizers of cytochrome P4502C19 in esophagus cancer, stomach cancer, lung cancer and bladder cancer in Chinese population[J]. World J Gastroenterol,2004,10(13):1961-1963.
[15] Roddam PL, Rollinson S, Kane E, et al. Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukaemia[J]. Pharmacogenetics, 2000,10(7):605-615.
[16] Modugno F,Knoll C,Kanbour-Shakir A.A potential role for hedestrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis[J]. Breast Cancer Res Treat, 2003,82(3):191-194.
[17] Tsunedomi R,Lixuka N,Hamamo Y, et al. Patterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinoma [J]. Int J Oncol,2005,27(3):661-667.
[18] Blaisdell J, Mohrenweiser H, Jackson J, et al.Identification and functional characterization of new potentially defective alleles of human CYP2C19[J]. Pharmacogenetics,2002,12(9):701- 711.
[19]周宏灏.遗传药
理学[M]. 北京：人民军医出版社, 2003.76-78.
转贴于 酷文网-论文下载中心 http://www.coolwen.net
共3页: 上一页 [1] [2] 3 下一页
网摘收藏:
当前位置:
载入中...
-> 在百度中搜索：
-> 在Google中搜索：